‘Keep on doing the steps’
The allure of scientific discovery has captivated Roshan Kumar since childhood, and he was eager “to study the science books” even in his early school days, he said. But he earned his undergraduate degree with very little experience in the lab — his university didn’t emphasize research, so his skills didn’t progress far beyond how to use a pipette.
“I only had critical knowledge at that time,” he said.
Kumar’s dream was to attend medical school and become a practicing physician. Because he couldn’t do extensive research as an undergraduate, he was unaware of career opportunities in the lab. When a medical school rejected his application, however, he entered a master’s program in an advanced academic setting that included more involved laboratory techniques. He began to realize the endless possibilities that a career in research held for him. He said he experienced personal growth and shifted his goal.
“It doubled my love for science,” he said. “From there onwards, I steered my whole vision toward research.”
During his doctoral studies at the University of Hyderabad in India, Kumar’s research focused on understanding the protein modifications that cause Parkinson’s disease. Some days were fruitless, producing little to no data, he said; other days were full of victory and progress. Throughout, he maintained a consistent mindset.
“There are phases, for sure, where things never work out for you,” he told himself. “But don’t lose hope. Believe in yourself. Keep on doing the steps.”
Kumar now is working toward completing his postdoctoral studies in Ruma Banerjee’s lab at the University of Michigan Medical School, where his goal is to characterize how metabolism regulates intestinal disease. He hopes to pursue a position in academia after he completes his postdoc and will begin his job search next year.
Friend or foe? Hydrogen sulfide’s dual role in metabolism
Hydrogen sulfide, or H2S, is a gas produced by three enzymes in mammalian cells as well as by the gut microbial metabolism. H2S is important for mitochondrial respiration and acts as a signaling molecule at low concentrations. At higher levels, however, H2S can inhibit complex IV in the electron transport chain of the mitochondria, killing the organelle that provides energy to cells.
Roshan Kumar, a postdoc at the University of Michigan, became particularly interested in this characteristic of H2S and its ability to modulate angiogenesis, neuronal processes and cardiovascular functions.
Inspired by his fascination with mitochondria and guided by his training in biochemical research, Kumar began to study the effects of H2S inhibition of respiratory complex IV in mitochondrial metabolism. He specifically was interested in environments with characteristically high levels of the gas due to microbial release, primarily the intestinal epithelia.
Kumar and his colleagues aimed to understand how saturation of electron transport chain complexes counteracts H2S toxicity in such locations. They recently found that H2S can induce glycolysis and inhibit oxidative phosphorylation. They also discovered that mammalian cells reprogram metabolism using sulfide quinone oxidoreductase, an enzyme required for H2S detoxification. This enzyme can establish a redox cycle by causing the reversal of succinate dehydrogenase, or respiratory complex II. This reversal regenerates coenzyme Q, a cofactor required for the clearance of H2S. In this process, fumarate, a citric acid cycle intermediate, acts as a terminal electron acceptor. This mechanism effectively oxidizes H2S and mitigates levels of toxicity.
This finding may help researchers understand certain gut-based conditions including colitis and colorectal cancer. Kumar is interested in pursuing this study by observing how H2S toxicity affects the body when it leaves the intestinal environment.
“A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H2S oxidation” was published in the Journal of Biological Chemistry in January 2022. Kumar and other winners of the JBC Tabor Award will give talks during a symposium on Sunday, March 26, at Discover BMB in Seattle.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Cadichon honored for academic achievement
She won the State University of New York at Old Westbury’s Dr. Henry Teoh Award for Outstanding Collegiate Science and Technology Entry Program Graduating Senior, which recognizes exceptional achievement, leadership and promise in a student.
In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.
From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.
Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.